Zhanling Cheng
Inventor
Stats
- 1 US patents issued
- 28 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 28 US Applications Filed
- 21 Total Citation Count
- May 31, 2023 Most Recent Filing
- Jun 10, 2015 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| HOFFMANN-LA ROCHE INC. | 1
2 1 | 2015
2016 2017 |
Inventor Addresses
| Address | Duration |
|---|---|
| Pudong, CN | Jan 12, 23 - Jan 12, 23 |
| Shanghai, CN | Sep 24, 15 - Jan 09, 25 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 15 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 15 |
| C07D: | HETEROCYCLIC COMPOUNDS | 27 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0011,326 | 2025 | FUSED HETEROCYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF HBV INFECTION | 0 |
| 2024/0287,070 | 2024 | FUSED HETEROCYCLIC DERIVATIVES | 0 |
| 2024/0279,227 | 2024 | FUSED HETEROCYCLIC DERIVATIVES | 0 |
| 2023/0257,354 | 2023 | NOVEL HETEROCYCLIC COMPOUNDS | 0 |
| 2023/0165,865 | 2023 | HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.